NABR Supports CITES Committee's Decision on Cambodian Macaques to Protect Biodiversity

NABR Applauds CITES Committee's Decision on Cambodian Macaques

On February 4, 2025, the National Association for Biomedical Research (NABR) expressed its approval of the CITES Standing Committee's decision to not impose a trade suspension on long-tailed macaques (Macaca fascicularis) sourced from Cambodia. This notable resolution signifies a collaborative effort among international stakeholders to prioritize transparency and scientific evidence amid ongoing debates concerning wildlife trade policies.

The CITES (Convention on International Trade in Endangered Species of Wild Fauna and Flora) organization is crucial for maintaining international agreements to ensure sustainable trade of wildlife species. In this case, Japan formally urged the CITES Standing Committee to postpone any immediate decisions until a subsequent meeting, a recommendation that garnered widespread support from several other nations including the United States, Canada, and Kuwait.

During the discussions held in Geneva, Switzerland, representatives from each participating nation underscored the necessity of reviewing the updated information submitted by Cambodia before any drastic measures could be taken. The committee succinctly pointed out that not a single nation endorsed the Secretariat's recommendation for an immediate trade suspension due to the reliance on flawed claims regarding the country’s macaque export practices.

NABR's president, Matthew R. Bailey, highlighted that this decision underscores a commitment to fact-based deliberation in matters of such gravity. He stated, “The availability of long-tailed macaques is paramount for biomedicine, particularly in the realm of research aimed at combating diseases such as cancer and other pressing health issues.” This point emphasizes the broader implications of wildlife trade decisions, which directly influence scientific progress and public health initiatives.

The committee's resolution paves the way for a comprehensive allocation of time and resources towards a detailed assessment by the CITES Secretariat. This includes plans for a formal delegation to visit Cambodia, ensuring that the entire procedural framework is underpinned by transparency and rigorous evaluation of the evidence provided. Such due diligence is essential not only for Cambodia but also for fostering greater trust in international wildlife trade frameworks.

Furthermore, this decision grants additional time for the U.S. House Natural Resources Committee to finalize its review and oversight related to this crucial matter. The situation is emblematic of the ongoing struggle between activist-driven narratives and scientifically grounded policy discussions regarding wildlife use in research.

NABR has reaffirmed its dedication to advocating for science-based policies that support ethical biomedical research and medical advancements. “Our organization will persist in collaborating with global stakeholders to defend the use of research animals responsibly,” stated Bailey. This commitment is vital for ensuring continued progress in life-saving medical research.

The National Association for Biomedical Research, established in 1979, operates as a nonprofit organization devoted to promoting humane and ethical practices in animal research. It supports an extensive network of members, including numerous universities, medical institutions, and biotechnology companies that rely on responsible animal research to enhance both human and animal health. Given the complexity of wildlife trade and its implications within biomedical research, NABR’s stance represents a significant voice in fostering an integrated approach to science and ethical practices. More information about NABR can be found at www.nabr.org.